The Valley Desk

NCT03759366 · Interventional trial

A Phase 3 Open-Label Study of Eculizumab in Pediatric Participants With Refractory Generalized Myasthenia Gravis (gMG)

Overall registry status Completed

Phase 3

Conditions Myasthenia Gravis, Myasthenia Gravis, Generalized, Myasthenia Gravis, Juvenile Form

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov